In-Silico Designed Multi-Epitope Vaccine Targets Epstein-Barr Virus Associated Burkitt Lymphoma
Researchers have computationally designed a multi-epitope vaccine candidate targeting Epstein-Barr virus-associated Burkitt lymphoma, showing favorable stability and immune response profiles.


